Mary Pat Lancelotta
Public Communications Contact bei ADAPTIVE BIOTECHNOLOGIES CORPORATION
Profil
Mary Pat Lancelotta is an Independent Director at Ultivue, Inc. and a Director at Target Cancer Foundation.
She was previously the VP-Corporate Marketing & Communications at Adaptive Biotechnologies Corp.
and the Senior Vice President-Commercial Operations at Lumicell, Inc. Lancelotta received her undergraduate degree from Boston College and her MBA from Columbia Business School.
Aktive Positionen von Mary Pat Lancelotta
| Unternehmen | Position | Beginn |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Public Communications Contact | - |
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | 19.08.2021 |
| Target Cancer Foundation | Director/Board Member | - |
Ehemalige bekannte Positionen von Mary Pat Lancelotta
| Unternehmen | Position | Ende |
|---|---|---|
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Corporate Officer/Principal | - |
Ausbildung von Mary Pat Lancelotta
| Boston College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Electronic Technology |
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| Target Cancer Foundation |
